CABOMETYX cpr pell 20 mg bte 30 pce
7680664710014
CH-66471
L01EX07
07.16.1.
Reimbursement limitations:
CABOMETYX
Pour le traitement des patients adultes atteints d’un carcinome des cellules rénales (renal cell carcinoma, …
1 / 3
google
Details
- Product number
- 6647101
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- cabozantinibum 20 mg ut cabozantinibi l-malas 25.34 mg, cellulosum microcristallinum, lactosum 15.54 mg, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.9 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, triacetinum, E 171, E 172 (flavum), pro compresso obducto.
Articles (1)
Cabometyx 20 mg, Filmtabletten
Filmtabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
25.34 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
15.54 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.9 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 5095.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2018
Authorization holder
IPSEN Pharma Schweiz GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 66471
- Drug name
- Cabometyx, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EX07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/12/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CABOMETYX cpr pell 20 mg bte 30 pce
- Description (DE)
- CABOMETYX Filmtabl 20 mg Ds 30 Stk
- Market launch
- 15/12/2017
- Narcotic (BTM)
- No